Physician profile
Steven Alan Widmer
NPI 1740418995
$8,055.06
in general payments reported to CMS, 2019-2025
12 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,371 · 2020: $192 · 2021: $169 · 2022: $2,482 · 2023: $177 · 2024: $431 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548 · Travel and Lodging: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.92 |
| Travel and Lodging | $293.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,478.71 | 2019-2025 | Triathlon, Mako, Citrefix |
| Arthrex, INC. | $1,455.68 | 2022 | |
| Rock Medical Orthopedics, INC. | $872.37 | 2022 | |
| Baudax Bio INC. | $83.04 | 2021 | |
| Smith+Nephew, INC. | $28.83 | 2025 | Redapt, Or3o Dual Mobility |
| Zimmer Biomet Holdings, INC. | $27.49 | 2019-2024 | Persona |
| Vertex Pharmaceuticals Incorporated | $25.12 | 2025 | |
| Medtronic, INC. | $23.41 | 2023 | Intellis Adaptivestim |
| Next Science LLC | $22.55 | 2021 | |
| Medline Industries LP | $12.90 | 2019 | |
| Heron Therapeutics, INC. | $12.51 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Widmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.